Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert P. Smith
Robert P. Smith
University of Chicago
Thymidylate synthase inhibitor
Medicine
Toxicity
Gastroenterology
Neutropenia
4
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I Study of an Oral Formulation of ZD9331 Administered Daily for 28 Days
2003
Journal of Clinical Oncology
Michael B. Sawyer
Mark J. Ratain
Donna Bertucci
Robert P. Smith
Richard L. Schilsky
Nicholas J. Vogelzang
Keith Shulman
Edwin C. Douglass
Gini F. Fleming
Show All
Source
Cite
Save
Citations (9)
Phase I S tudy o f a n O ral F ormulation o f Z D9331 A dministered Daily f or 2 8 D ays
2003
Michael Sawyer
Mark J. Ratain
Donna Bertucci
Robert P. Smith
Richard L. Schilsky
Nicholas J. Vogelzang
Keith Shulman
Edwin C. Douglass
Gini F. Fleming
Show All
Source
Cite
Save
Citations (0)
Phase I Study of ZD9331 on Short Daily Intravenous Bolus Infusion for 5 Days Every 3 Weeks With Fixed Dosing Recommendations
2001
Journal of Clinical Oncology
B.C. Goh
Mark J. Ratain
Donna Bertucci
Robert P. Smith
Sridhar Mani
N. J. Vogelzang
Richard L. Schilsky
M. Hutchison
M. Smith
S. Averbuch
E. Douglass
Show All
Source
Cite
Save
Citations (30)
Phase I S tudy o f Z D9331 o n S hort D aily I ntravenous B olus Infusion f or 5 D ays E very 3 W eeks W ith F ixed D osing Recommendations
2001
Mark J. Ratain
Donna Bertucci
Robert P. Smith
Sridhar Mani
M. Hutchison
M. Smith
S. Averbuch
E. Douglass
Show All
Source
Cite
Save
Citations (0)
1